Want to join the conversation?
$CMS 2Q15 PR: Operating revenue was $1,350MM, down 8.04% from $1,468MM in 2Q14. OpEx was $1,146MM, down 7.06% from $1,233MM in 2Q14. 1H15: Operating revenue was $3,461MM, down 13.28% from $3,991MM in 2Q14. OpEx was $2,860MM, down 14.58% from $3,348MM in 2Q14.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.